Merck

Phase 3 Trial for Melanoma Treatment

  • Post author:
  • Post category:News
  • Post comments:0 Comments
  • Post last modified:July 31, 2023

Merck & Co. (MRK) and Moderna Inc. (MRNA) have announced the initiation of a Phase 3 trial to evaluate the efficacy of Moderna's V940 in combination with Merck's Keytruda as…